Telemedicine for pain patients during COVID-19: Survey of acceptance, satisfaction and preference (Preprint)

Author:

Harnik Michael AlexanderORCID,Scheidegger Alina,Blättler Larissa,Nemecek Zdenek,Sauter Thomas C.ORCID,Limacher Andreas,Reisig Florian,grosse Holtforth Martin,Streitberger Konrad

Abstract

BACKGROUND

The COVID-19 pandemic has forced many healthcare providers to make changes in the treatments they offer. We evaluated acceptance of telemedicine and preferences.

OBJECTIVE

The primary aim was to evaluate the acceptance of telemedicine during the COVID-19 pandemic in Switzerland. Further, to assess patients’ preferences and correlation between acceptance and satisfaction, pain, general condition, perception of telemedicine, and catastrophizing.

METHODS

Anonymous cross-sectional survey between 27/01/2021 and 04/02/2022, enrolling outpatients. Descriptive analysis of acceptance of telemedicine and investigation of patients’ preferences. Further, Spearman correlation and a chi-squared test for categorical data, with Cramer’s V statistic to assess effect sizes.

RESULTS

Our survey was completed by 60 patients. Telemedicine acceptance was high, with an average of 7.6±3.3 (on an 11-point numeric rating scale from 0 = not at all to 10 = completely), and respondents generally preferred on-site consultations over telemedicine (58.3% vs. 40.0%). A subgroup analysis revealed that respondents who already had received a phone consultation, showed higher preference for telemedicine (50.0% vs. 16.7%; X2 (2, n=60) = 7.5, P=.024, Cramer's V=.354), as well as those who had been treated for more than 3 months (54.8% vs. 24.1%; X2 (2, n=60) = 6.5, P=.039, Cramer's V=.329).

CONCLUSIONS

Acceptance of telemedicine was high, but patients preferred on-site consultations. Preference for telemedicine was markedly higher in patients who had already received phone consultations or who had been treated for longer than 3 months. In times of COVID-19, the modality of patient care should be discussed on an individual basis.

CLINICALTRIAL

No registration.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3